Eli Lilly and Co (NYSE:LLY)

109.51
Delayed Data
As of Aug 23
 -2.10 / -1.88%
Today’s Change
103.66
Today|||52-Week Range
132.13
-5.37%
Year-to-Date
AstraZeneca's Kidney Drug Roxadustat Gets Second Nod in China
Aug 22 / Zacks.com - Paid Partner Content
Bayer Sells Animal Health Division to Elanco: Now What?
Aug 20 / Zacks.com - Paid Partner Content
NuCana Stops Patient Enrollment in Pancreatic Cancer Study
Aug 21 / Zacks.com - Paid Partner Content
Better Buy: Eli Lilly vs. GlaxoSmithKline
Aug 18 / MotleyFool.com - Paid Partner Content
3 Top Diabetes Stocks to Watch in August
Aug 21 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Pipeline/Regulatory Updates From JNJ, LLY, AZN, RHHBY
Aug 16 / Zacks.com - Paid Partner Content
Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice
Aug 21 / Zacks.com - Paid Partner Content
Gilead's (GILD) Filgotinib MAA for RA Accepted in Europe
Aug 16 / Zacks.com - Paid Partner Content
Bayer Inks $7.6B Deal to Divest Animal Health Unit to Elanco
Aug 21 / Zacks.com - Paid Partner Content
Agios Rides High on Tibsovo Sales Amid Acute Competition
Aug 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close111.61
Today’s open111.46
Day’s range108.88 - 112.56
Volume3,870,286
Average volume (3 months)4,337,201
Market cap$106.7B
Data as of 6:30pm ET, 08/23/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+3.14%
Earnings growth (next 5 years)+9.70%
Revenue growth (last year)+7.36%
P/E ratio26.0
Price/Sales4.87
Price/Book11.88

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.01+0.02%
GSKGlaxoSmithKline+0.21+0.51%
ABBVAbbVie-1.55-2.30%
AZNAstraZeneca-0.83-1.83%
Data as of 6:30pm ET, 08/23/2019

Financials

Next reporting dateOctober 23, 2019
EPS forecast (this quarter)$1.41
Annual revenue (last year)$24.6B
Annual profit (last year)$3.2B
Net profit margin13.16%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
David A. Ricks
Senior VP &
President-Manufacturing Operations
Myles Oneill
Corporate headquarters
Indianapolis, Indiana

Forecasts